Equity
€264,150 from €15.0m in 2009
Equity fell by 98% in 16 years.
APITOPE INTERNATIONAL
Lifetime
17 annual accounts with figures on one time axispeak €1.4m (2021)
€475,244▲ €491,762
lowest -€5.0m (2015)
€471,830▲ €546,128
peak €15.0m (2009)
€264,150▲ 524%
€288,913▲ 496%
peak 11.5 FTE (2014)
-not published
Board13 names since 2015all names
3 directors and 2 others
Owners4 names in the annual accounts
28.5%
Documentsfilings and deeds
23-03-2026130 days before the deadline
2025micro format
Gross margin from -€16,518 to €475,244Back to profit: €471,8301 director reappointed 22-05Dividend €250,000Equity from €42,320 to €264,150Debts from €48,504 to €288,913
Key points
from the 2025 annual accountsTurnover
≈ €710,000 estimated
The accounts state no turnover.
Position in the sector
€471,830
Higher net result than 95% of companies in human health. Sector median €59,542 · 21,298 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 17,811 companies had the same profile as APITOPE INTERNATIONAL has now. Each dot stands for 45 companies, two years later.
96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 17,811 companies, not a prediction for APITOPE INTERNATIONAL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, since 23-04-2019
Director, since 31-05-2021
Director,
- 28.5%equity €521.2m (2025) · 2025 annual accounts of
- 2.71%equity €3.8m (2023) · 07-09-2023 annual accounts of
Recent changes
1 director reappointed
· Permanent representatives: and · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0807253103
2 directors reappointed
and · Permanent representatives: and · General meeting of 31-05-2021 · Gazette deed
Capital increase of €10,768,392.39
Capital decrease of €12,120,151.30 · Capital decrease of €8,312,529.28 · Capital of €159,609.06 · General meeting of 31-01-2022 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| APITOPE INTERNATIONAL Diepenbeek | €553,063 | €475,244 | 47.8% | - |
| CENTRE DE RADIOLOGIE DU BOIS DE LA PIERRE Chaumont-Gistoux | €609,822 | €404,001 | 13.2% | 4 |
| Oogartspraktijk Filip Mergaerts Aarschot | €728,857 | €456,945 | 76.8% | 4.4 |
| Dr Katia Mekeirele Waregem | €707,417 | €386,792 | 94.5% | - |
| Dr.Isabelle VAN MIEGHEM,radioloog Hasselt | €472,990 | €291,503 | 60.1% | 1.7 |
| CENTRE D'IMAGERIE MEDICALE ET DE RADIOLOGIE Mons | €832,235 | €487,544 | 72.6% | - |
| DOKTER DANA VAN KERKHOVEN Olen | €666,673 | €510,245 | 45.0% | - |
These companies have the same main activity as APITOPE INTERNATIONAL: medical imaging and medical laboratories (NACE 86910). They are comparable in size and age: total assets between €473,000 and €832,000, founded between 2006 and 2013.
Official details
Source: KBO- Status
- Active since 21-10-2008Normal situation
- Activity
- Medical imaging and medical laboratoriesNACE 86910
- Joint committee
- 330Health institutions and services · annual accounts 2023
- Establishment unit
- 2.176.236.9663590 Diepenbeek, since 21-10-2008
- Financial year end
- 31 December
- Peppol
- Reachable since 24-11-2023
Annual accounts 2025
- €553,063▲ 509%
- Filing
- Filed on 23-03-2026, 130 days before the end of the filing period
Insights on APITOPE INTERNATIONAL
APITOPE INTERNATIONAL files the micro format. That format states no turnover. The gross margin rose from -€1.4m in 2009 to €475,244 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about APITOPE INTERNATIONAL
- What is the company number of APITOPE INTERNATIONAL?
- The company number of APITOPE INTERNATIONAL is 0807.253.103. The VAT number is the same number with BE in front: BE 0807.253.103.
- Where is APITOPE INTERNATIONAL based?
- The registered office is at Agoralaan A-BIS, 3590 Diepenbeek.Company details
- What does APITOPE INTERNATIONAL do?
- According to the KBO register, the main activity is medical imaging and medical laboratories (NACE 86910).
- What is the legal form of APITOPE INTERNATIONAL?
- APITOPE INTERNATIONAL is a public limited company (NV).
- When was APITOPE INTERNATIONAL founded?
- APITOPE INTERNATIONAL was founded on 21-10-2008.
- Is APITOPE INTERNATIONAL still active?
- Yes, APITOPE INTERNATIONAL is an active enterprise in the KBO register.
- How many employees does APITOPE INTERNATIONAL have?
- APITOPE INTERNATIONAL had an average of 0.8 full-time equivalents in financial year 2021, according to the filed annual accounts.Financials
- Which joint committee does APITOPE INTERNATIONAL fall under?
- In its 2023 annual accounts, APITOPE INTERNATIONAL states joint committee 330 (Health institutions and services).
- What is the turnover of APITOPE INTERNATIONAL?
- The turnover in financial year 2025 is ≈ €710,000. This figure is estimated from the gross margin of €475,244 and 46 comparable companies (NACE 86). It probably lies between €590,000 and €900,000.
- Is APITOPE INTERNATIONAL profitable?
- In financial year 2025, APITOPE INTERNATIONAL made a profit of €471,830.
- Where can I find the annual accounts of APITOPE INTERNATIONAL?
- APITOPE INTERNATIONAL filed 17 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of APITOPE INTERNATIONAL due?
- APITOPE INTERNATIONAL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.